Skip to main content
GLASF
OTC Life Sciences

CEO Kyle Kazan Files Intent to Sell $1.4M in Shares Acquired via RSU Vesting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
7
Price
$11.61
Mkt Cap
0
52W Low
$4.55
52W High
$11.73
52W Position info
155% above low
Off High info
1.0% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GLASF has more than doubled off its 52-week low of $4.55.

Summary

Glass House Brands CEO Kyle Kazan has filed a Form 144 indicating his intent to sell 125,000 shares, valued at approximately $1.42 million, which were acquired through RSU vesting.


Key Events · Ownership and Investor Activity · GLASF

  • CEO Files Intent to Sell Shares

    Kyle Kazan, Chairman and CEO, has filed a Form 144 indicating his intent to sell 125,000 shares of Glass House Brands Inc.

  • Significant Proposed Sale Value

    The approximate market value of the shares intended to be sold is $1,416,250.00.

  • Shares Acquired via RSU Vesting

    The shares were acquired through employment-related RSU vesting, with the proposed sale date set for June 11, 2026.

  • Trading Near 52-Week Highs

    The proposed sale occurs while the company's stock is trading near its 52-week high of $11.73.


Analysis · GLASF · Life Sciences

This Form 144 indicates that CEO Kyle Kazan intends to sell a significant block of shares, valued at over $1.4 million, which he received through RSU vesting. While sales related to vesting are common for compensation, this disposition by the top executive, especially with the stock trading near its 52-week high, adds to the existing insider selling trend observed over the past 90 days. This could be interpreted as the CEO taking profits and diversifying his holdings.

At the time of this filing, GLASF was trading at $11.61 on OTC in the Life Sciences sector. The 52-week trading range was $4.55 to $11.73. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GLASF - Latest Insights

GLASF
Jun 18, 2026, 5:25 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $13.58
Real-time Price: $12.40 info
Change: -$1.18 (-9%) info
Market Cap: $955.441M info
GLASF
Jun 17, 2026, 10:39 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $13.32
Real-time Price: $12.40 info
Change: -$0.920 (-7%) info
Market Cap: $955.441M info
GLASF
Jun 04, 2026, 5:00 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $12.40 info
Change: +$0.790 (+7%) info
Market Cap: $955.441M info
GLASF
May 13, 2026, 4:17 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.04
Real-time Price: $12.40 info
Change: +$3.36 (+37%) info
Market Cap: $955.441M info
GLASF
Apr 28, 2026, 6:33 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $10.39
Real-time Price: $12.40 info
Change: +$2.01 (+19%) info
Market Cap: $955.441M info
GLASF
Mar 24, 2026, 5:08 PM EDT
Filing Type: 40-F
Importance Score:
8
Price at Filing: $7.95
Real-time Price: $12.40 info
Change: +$4.45 (+56%) info
Market Cap: $955.441M info
GLASF
Mar 24, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $7.95
Real-time Price: $12.40 info
Change: +$4.45 (+56%) info
Market Cap: $955.441M info